{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T12:51:06Z","timestamp":1770987066768,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1016\/j.pnpbp.2006.01.024","type":"journal-article","created":{"date-parts":[[2006,3,8]],"date-time":"2006-03-08T12:21:46Z","timestamp":1141820506000},"page":"745-747","source":"Crossref","is-referenced-by-count":15,"title":["Acute dystonia after initial doses of ziprasidone: A case report"],"prefix":"10.1016","volume":"30","author":[{"given":"Mehmet","family":"Yumru","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haluk A.","family":"Savas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salih","family":"Selek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esen","family":"Savas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2006.01.024_bib1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1176\/appi.neuropsych.15.2.241","article-title":"Acute dystonia caused by low dosage of olanzapine","volume":"15","author":"Alevizos","year":"2003","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.pnpbp.2006.01.024_bib2","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"1994"},{"key":"10.1016\/j.pnpbp.2006.01.024_bib3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0014-2999(01)01188-8","article-title":"Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile","volume":"425","author":"Schmidt","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2006.01.024_bib4","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/00004714-199612000-00012","article-title":"Acute dystonia induced by rapid increase in risperidone dosage","volume":"16","author":"Brody","year":"1996","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2006.01.024_bib5","series-title":"Drug-induced movement disorders","first-page":"21","article-title":"Neuroleptic\u2212induced acute dystonia","author":"Casey","year":"1992"},{"key":"10.1016\/j.pnpbp.2006.01.024_bib6","first-page":"545","article-title":"Neuroleptic-induced acute dystonia","volume":"vol. 1","author":"Casey","year":"1994"},{"key":"10.1016\/j.pnpbp.2006.01.024_bib7","first-page":"69","article-title":"Therapeutic strategies for the patient with treatment-resistant anxiety","volume":"54","author":"Coplan","year":"1993","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.01.024_bib8","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1017\/S1092852900010002","article-title":"Ziprasidone as an augmenting agent in the treatment of anxiety-spectrum disorders","volume":"10","author":"Crane","year":"2005","journal-title":"CNS Spectr"},{"key":"10.1016\/j.pnpbp.2006.01.024_bib9","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/01.jcp.0000138780.55762.36","article-title":"Acute dystonic reaction with moderate-dose ziprasidone","volume":"24","author":"Dew","year":"2004","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2006.01.024_bib10","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/mds.1154","article-title":"Acute paroxysmal dystonia induced by fluoxetine","volume":"16","author":"Dominguez-Moran","year":"2001","journal-title":"Mov Disord"},{"key":"10.1016\/j.pnpbp.2006.01.024_bib11","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1176\/appi.ajp.157.4.659-a","article-title":"Olanzapine and panic attacks","volume":"157","author":"Etxebeste","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.01.024_bib12","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/archpsyc.1989.01810110048007","article-title":"The Yale brown obsessive compulsive scale: I. Development, use and reliability","volume":"46","author":"Goodman","year":"1989","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.01.024_bib13","first-page":"20","article-title":"Refractory obsessive-compulsive disorder: state-of-the-art treatment","volume":"63","author":"Hollander","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.01.024_bib14","series-title":"Comprehensive textbook of psychiatry","first-page":"2003","author":"Kaplan","year":"1995"},{"key":"10.1016\/j.pnpbp.2006.01.024_bib15","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1345\/aph.1D411","article-title":"Quetiapine-associated acute dystonia","volume":"38","author":"Kropp","year":"2004","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.pnpbp.2006.01.024_bib16","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1176\/ajp.156.11.1834-a","article-title":"Effectiveness of olanzapine treatment for severe obsessive-compulsive disorder","volume":"156","author":"Marazziti","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.01.024_bib17","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1192\/bjp.177.6.567-a","article-title":"Antidepressant augmentation with low-dose olanzapine in obsessive-compulsive disorder","volume":"177","author":"Marusic","year":"2000","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.01.024_bib18","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1176\/appi.ajp.162.3.625-a","article-title":"Ziprasidone-induced acute dystonia","volume":"162","author":"Mason","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.01.024_bib19","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/01.CHI.0000070257.24125.91","article-title":"Ziprasidone-induced oculogyric crisis","volume":"42","author":"Ramos","year":"2003","journal-title":"J Am Acad Child Adolesc Psych"},{"key":"10.1016\/j.pnpbp.2006.01.024_bib20","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1136\/bmj.319.7210.623","article-title":"Acute dystonia induced by drug treatment","volume":"319","author":"van Harten","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.pnpbp.2006.01.024_bib21","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00131746-200203000-00004","article-title":"Best clinical practice with ziprasidone: update after one year of experience","volume":"8","author":"Weiden Peter","year":"2002","journal-title":"J Psychiatr Pract"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584606000509?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584606000509?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T18:05:04Z","timestamp":1683396304000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584606000509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S0278584606000509"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2006.01.024","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}